Back to top

Lexicon (LXRX) Regains Compliance with Nasdaq's Minimum Bid Rule

Lexicon (LXRX) Regains Compliance with Nasdaq's Minimum Bid Rule

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Lexicon Pharmaceuticals, Inc. (LXRX)